CQE´s researchers work cited on drug safety warnings

The cutting-edge research conducted by CQE's Cátia Marques, Gonçalo Justino and Matilde Marques has provided invaluable insights into the biological and toxicological activity of Singulair, particularly regarding the incidence of neuropsychiatric effects on children and contributing to their understanding at a molecular and pathway level. Notably, the expertise of CQE's researchers has garnered recognition on a global scale, with their insights being sought after by reputable sources. Recently, the New York Times consulted our researchers, further affirming the impact and relevance of our work in advancing the scientific knowledge surrounding the safety profile of this and other drugs. In parallel, Scientific American has also reached out for comments on this asthma drug still being prescribed to kids despite potential mental health risks.

LINK New York Times:
"The F.D.A. Warned an Asthma Drug Could Induce Despair. Many Were Never Told."

LINK Scientific American:
"Asthma Drug Still Being Prescribed to Kids Despite Potential Mental Health Risks"

Photo by: Alihan Usully / Getty images